These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 26489873)

  • 21. A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety.
    Francis JN; Bunce CJ; Horlock C; Watson JM; Warrington SJ; Georges B; Brown CB
    Vaccine; 2015 Jan; 33(2):396-402. PubMed ID: 24928790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
    Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein Vaccination Directs the CD4
    Rattan A; Richards KA; Knowlden ZAG; Sant AJ
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.
    Mohn KG; Cox RJ; Tunheim G; Berdal JE; Hauge AG; Jul-Larsen Å; ; Peters B; Oftung F; Jonassen CM; Mjaaland S
    PLoS One; 2015; 10(11):e0143281. PubMed ID: 26606759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
    Adhikari UK; Rahman MM
    Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human influenza viruses and CD8(+) T cell responses.
    Grant EJ; Quiñones-Parra SM; Clemens EB; Kedzierska K
    Curr Opin Virol; 2016 Feb; 16():132-142. PubMed ID: 26974887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.
    Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC
    Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.
    Liu J; Wu B; Zhang S; Tan S; Sun Y; Chen Z; Qin Y; Sun M; Shi G; Wu Y; Sun M; Liu N; Ning K; Ma Y; Gao B; Yan J; Zhu F; Wang H; Gao GF
    Eur J Immunol; 2013 Aug; 43(8):2055-69. PubMed ID: 23681926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 30. A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.
    Di Mario G; Garulli B; Sciaraffia E; Facchini M; Donatelli I; Castrucci MR
    Virol J; 2016 Mar; 13():56. PubMed ID: 27036323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform.
    Szurgot I; Szolajska E; Laurin D; Lambrecht B; Chaperot L; Schoehn G; Chroboczek J
    Vaccine; 2013 Sep; 31(40):4338-46. PubMed ID: 23880363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conserved peptides containing overlapping CD4+ and CD8+ T-cell epitopes in the H1N1 influenza virus: an immunoinformatics approach.
    Lohia N; Baranwal M
    Viral Immunol; 2014 Jun; 27(5):225-34. PubMed ID: 24821387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen.
    Chauvat A; Benhamouda N; Loison E; Gougeon ML; Gey A; Levionnois E; Ravel P; Abitbol V; Roncelin S; Marcheteau E; Quintin-Colonna F; Fridman WH; Launay O; Tartour E
    J Immunol Methods; 2012 Apr; 378(1-2):81-7. PubMed ID: 22366633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Nieuwkoop NJ; Spronken MI; van de Vijver DA; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2016 Jan; 90(2):1009-22. PubMed ID: 26537686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans.
    Assarsson E; Bui HH; Sidney J; Zhang Q; Glenn J; Oseroff C; Mbawuike IN; Alexander J; Newman MJ; Grey H; Sette A
    J Virol; 2008 Dec; 82(24):12241-51. PubMed ID: 18842709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
    van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice.
    Alexander J; Bilsel P; del Guercio MF; Stewart S; Marinkovic-Petrovic A; Southwood S; Crimi C; Vang L; Walker L; Ishioka G; Chitnis V; Sette A; Assarsson E; Hannaman D; Botten J; Newman MJ
    Vaccine; 2010 Jan; 28(3):664-72. PubMed ID: 19895924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a First Human Norovirus CD8
    Malm M; Vesikari T; Blazevic V
    Front Immunol; 2018; 9():2782. PubMed ID: 30542352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination.
    Danke NA; Kwok WW
    J Immunol; 2003 Sep; 171(6):3163-9. PubMed ID: 12960344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.
    Choo JA; Liu J; Toh X; Grotenbreg GM; Ren EC
    J Virol; 2014 Sep; 88(18):10613-23. PubMed ID: 24990997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.